Guided Therapeutics
This article was originally published in The Gray Sheet
Executive Summary
Firm submits the first of three PMA modules for its LightTouch non-invasive cervical cancer detection device, announced Dec. 10. The completed application will include results from a pivotal trial of 1,900 women. LightTouch is designed to identify cancer and pre-cancer by analyzing the wavelengths of light reflected from cervical tissue, Guided Therapeutics explains